Tesamorelin Dosage Calculator & Research Doses

1Set Up Your Mix

5 mg/mL · 5000 mcg/mL

1. Pick your peptide

2. How much peptide is in the vial? It's printed on the label — usually something like 5 mg

3. How much water are you adding? More water makes each dose easier to measure

4. How much do you want per dose?

All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — TesamorelinYour Answer

—

20Draw To This Line

0.2That's This Many mL

5Doses In The Vial

5 mg ÷ 1 mL = 5 mg/mL → 1 mg ÷ 5 mg/mL = 0.2 mL → × 100 = 20 units—

Looks good. Draw to 20 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 5 doses.

2Week-By-Week Plan — Tesamorelin

Start low, work up

When	Dose	How Often	How Many mL	Draw To	Number Of Doses
Label dose	2 mg	1× daily	0.4 mL	40 u	2 doses
Lower reported	1 mg	1× daily	0.2 mL	20 u	5 doses
Trial arm	2 mg	daily, 26–52 wk	0.4 mL	40 u	2 doses

Weeks until the top dose

2 weeks

Peptide used getting there

14 mg

Vials you'll need

3 × 5 mg

Once you're at the top dose

56 mg / 4 wk · 11.2 vials

Where this plan came from

Built from this peptide's dose range

Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — Tesamorelin

worked out for your mix

Level	Dose	How Often	How Many mL	Draw To	Doses In Vial
Weeks 1–2	1 mg	daily	0.2 mL	20 u	14	14 mg
Week 3 onward per 4 weeks from here on	2 mg	daily	0.4 mL	40 u	28	56 mg

Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About TesamorelinAbout This Peptide

GH Secretagogue

Also known as

TH9507, Egrifta

Class

GH Secretagogue

Route

Subcutaneous

Half-life

~26–38 min

Evidence tier

Clinical

An FDA-approved GHRH analogue for HIV-associated lipodystrophy — the only compound in this class with a full approval and a defined label dose. Two large phase 3 trials support the 2 mg daily figure.

Buy Tesamorelinthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Clinical — Human trial or approved-label dosing published

Effects of tesamorelin on visceral fat in HIV-associated lipodystrophy Falutz J, et al. New England Journal of Medicine, 2007

The pivotal phase 3 trial establishing 2 mg daily.

Find on PubMed ↗

Long-term safety and effects of tesamorelin — 52-week extension Falutz J, et al. AIDS, 2010

Extended safety and durability data at the same dose.

Find on PubMed ↗

Effects of tesamorelin on liver fat and cognition Stanley TL, et al. The Lancet HIV / JAMA, 2019

Later trials extending the indication evidence beyond visceral fat.

Find on PubMed ↗

Newest Studies — —

—

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Research Use Only — Confirm to Continue

Tesamorelin Dosage & Reconstitution

1Set Up Your Mix

Your Answer — TesamorelinYour Answer

2Week-By-Week Plan — Tesamorelin

3Common Doses — Tesamorelin

About TesamorelinAbout This Peptide

Where These Numbers Come From

Newest Studies — —

More peptides

Sermorelin

GHRP-2

All 71 peptides